Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs
Clyde Dapat1, Yasushi Suzuki, Reiko Saito
1Department of Public Health, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan. clyde@med.niigata-u.ac.jp
Abstract:
In 2007 and 2008 in Myanmar, we detected influenza viruses A (H3N2) that exhibited reduced sensitivity to both zanamivir and amantadine. These rare and naturally occurring viruses harbored a novel Q136K mutation in neuraminidase and S31N mutation in M2.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
12:09Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
Related Concept Videos
Influenza
Inhibitors Of Virion Release
Retrovirus Life Cycles
Viral Mutations
Antiviral Nucleoside Inhibitors
Viral Recombination
